Bibliografía del artículo
1. Lavie CJ, Milani RV, Littman AB. Marked benefits of cardiac rehabilitation and excercise training in secondary coronary prevention in the elderly. J Am Coll Cardiol 22:678-683, 1993.
2. Pesonen E, Norio R, Hirvonen J, Karkola K, Kuusela V, Laaksonen H, et al. Intimal thickening in the coronary arteries of infants and children as an indicator of risk factors for coronary heart disease. Eur Heart J 11:53-60, 1990.
3. Goldberg RJ, Gore JM, Gurwitz JH et al. The impact of the age on the incidence and prognosis of initial acute myocardial infarction: The Worcester Heart Attack Study. Am Heart J 117:543-549, 1989.
4. Castelló R, Alegría E, Merino A, Aparici M, Calabuig J, Martínez-Caro D. Evolución a medio plazo de los pacientes mayores de 65 años con infarto agudo de miocardio. Rev Esp Cardiol 41:78-82, 1988.
5. World Health Organization: World Health Statistics Annual, Geneva, 1979.
6. Cuomo S, Guarini P, Gaeta G, De Michele M, Boeri F, Dorn J, Bond MG and Trevisan M. Increased carotid intima-media thickness in children-adolescents, and young adults with a parental history of premture myocardial infarction. Eur Heart J 23:1345-1350, 2002.
7. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 19:A53-A61, 1998.
8. Gohlke-Bärwolf C. Coronary artery disease - is menopause a risk factor? Basic Res Cardiol 95:I/77-I/83, 2000.
9. Dorman JS, Steenkiste AR, Foley TP, Strotmeyer ES, Burke JP, Kuller LH, Kwoh CK. Menopause in type 1 diabetic women: is it premature? Diabetes 50(8):1857-1862, 2001.
10. Whelton PK, Appel LJ, Espeland MA, et al. For the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmacologic intervention in the elderly (TONE). JAMA 279:839-846, 1998.
11. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of th effects of dietary patterns on blood pressare: results from the Dietary Approachs to Stop Hypertension (DASH) trial. N Engl J Med 336:1117-1124, 1997.
12. Paterno CA. Factores de riesgo coronario en la adolescencia. Estudio FRICELA. Rev Esp Cardiol 56:452-458, 2003.
13. Pearl R. Tobacco smoking and longevity. Science 87:216-217, 1938.
14. Both FW, Gordon SE, Carlson CHJ, Hamilton MT. Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol 88:774-787, 2000.
15. Saltin B, Blomquist G, Mitchell JH et al. Response to exercise after bed rest and after training. A longitudinal study of adaptative changes in oxygen transport and body composition. Circulation 38(Suppl.7):vii, 1968.
16. Nocon M, Hiemann T, Müller-Riemenschneider, Thalau F, Roll S and Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 15:239-46, 2008.
17. Churchill JD, Galvez R, Colcombe ST, Swain RA, Kramer AF, Greenough WT. Exercise, experience and the aging brain. Neurobiol Aging 23:941-955, 2002.
18. Boraita Pérez A. Ejercicio, piedra angular de la prevención cardiovascular. Rev Esp Card 61(5):514-28, 2008.
19. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med 333:677-85, 1995.
20. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105:1696-98, 2002.
21. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 115(Suppl.8A):37S-41S, 2003.
22. American Diabetes Association, the National Heart, Lung and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Disease, and the American Heart Association. Diabetes mellitus: a major risk factor for cardiovascular Disease. Circulation 100:1132-3, 1999.
23. Alegría Ezquerra E, Castellano Vázquez JM, Alegría Barrero A. Obesidad, sindrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica. Rev Esp Card 61(7):752-64, 2008.
24. Vokonas RS, Kannel WB. Diabetes mellitus and coronary heart disease in the elderly. Clin Geriatr Med 12(1):69-78, 1996.
25. Grundy SM, Benjamín IJ, Burke GL, Chait A, Eckel RH, Howard BV et al. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146, 1999.
26. University Group Diabetes Program. A study of the effects of hypoglicemic agents on vascular complications in patients with adult-on-set diabetes II. Mortality results. Diabetes 19(Suppl.2):785-930, 1976.
27. Shepherd J, Cobe S, Ford I, Isles C, Ross A, Macfarlane P et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307, 1995.
28. The concept of doctor targets based on quality guidelines: focus on blood pressure. David Wood. E H J Suppl B-B29-B36, 2007.
29. Levy D, Wilson PWF, Anderson KM, and Castelli WM. Stratifying the patient at risk from coronary disease: New insights from the Framingham Heart Study. Am Heart J 119:712, 1990.
30. Chase HP, Garg SK, Harris S, et al. High-normal blood pressure and early diabetic nephropathy. Arch Inter Med 150:639, 1990.
31. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 288:1882-88, 2002.
32. Haider AW,Larson MG, Franklin SS, Levy D, for the Framingham Heart Study. Systolic blood pressure, diastolic blood pressure, and polse pressure as predictors of risk for confestive heart failure in the Framingham Heart Study. Ann Intern Med 138:10-6, 2003.
33. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 371:1513-18, 2008.
34. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlortalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288(283):2981-97(1967-75), 2002.
35. Beckett NS, Fletcher AE, Bulpitt CJ et al for the HYVET Study Group. Treatment of Hypertension in patients 80 years of age or older. N Engl J Med 358:1887-1898, 2008.
36. Avolio AP, Fa-Quan D, Wei-Qiang L, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: Comparison between urban and rural communities in China. Circulation 71:202, 1985.
37. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutritional Examination Survey, 1988-1991. Hypertension 25:305-313, 1995.
38. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. Mortality by race, sex, and age. JAMA 242:2572, 1979.
39. European Working Party on High Blood Pressure in the Elderly: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1:1349, 1985.
40. Jajich CL, Ostfeld AM, and Freeman DH: Smoking and coronary heart disease mortality in the elderly. JAMA 252:2831, 1984.
41. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium relates hormones in the Yanomamo Indians, a "no salt" culture. Circulation 52:146-151, 1975.
42. Mancilha-Carvalho JJ, De Oliveira R, Esposito RJ. Blood pression and electrolyte excretion in the Yanomamo indians, isolated population. J Hum Hypertens 3:309-314, 1989.
43. Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Eur Heart J 23:528-535, 2002.
44. Neaton JD, Wentworth D, for the Multiple Risk Factors Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316 099 white men. Arch Intern Med 152:56-64, 1992.
45. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular desease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Int Med 158:2007-14, 1998.
46. WHO-MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. Wld Hlth Stat Q 41:115-40, 1988.
47. Plaza Pérez I, Villar Alvarez F, Mata López P, Pérez Jiménez F, Maiquez Galán A, Casasnovas Lengas JA, Banegas Banegas JR, et al. Control de la colesterolemia en España, 2000. Un instrumento para la prevenciòn cardiovascular. Rev Esp Cardiol 53:815-837, 2000.